February 4, 2019 by Chain Drug Review
Hy-Vee, opioid abuse crisis
February 4, 2019, News
WEST DES MOINES, Iowa — To assist in combatting the national opioid epidemic, Hy-Vee Inc. has implemented a new controlled substance prescription policy. Since January 1, Hy-Vee pharmacies have not allowed a subsequent fill of a Schedule II controlled substance, or a refill of a Schedule III or Scheduled IV controlled substance more than 72
February 4, 2019 by Chain Drug Review
CVS Pharmacy, Judy Sansone
February 4, 2019, News
WOONSOCKET, R.I. — CVS Pharmacy has expanded the responsibilities of Judy Sansone, the chain’s senior vice president of front-store business and chief merchant. In addition, George Coleman has been promoted to senior vice president of merchandising, reporting to Sansone. He had been vice president of merchandising for consumer health care. Sansone’s team will be responsible
February 4, 2019 by Chain Drug Review
Microsoft, WBA
February 4, 2019, News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) and Microsoft Corp. have teamed up to develop new health care delivery models, technology and retail innovations to advance and improve the future of health care. The companies will combine the power of Microsoft Azure, Microsoft’s cloud and artificial intelligence platform, health care investments, and new retail solutions
February 4, 2019 by Chain Drug Review
CVS, CVS Beauty Mark
February 4, 2019, News
WOONSOCKET, R.I. — CVS Pharmacy, the retail division of CVS Health, announced significant progress toward the goal of full transparency for all of its beauty imagery by the end of 2020 and its efforts to create new industry standards for post-production alterations of beauty imagery. Just one year after the company made the commitment to
February 4, 2019 by Chain Drug Review
DIR fee reform, NACDS
February 4, 2019, News
ARLINGTON, Va. — The National Association of Chain Drug Stores has submitted extensive and thoroughly documented comments to the Centers for Medicare and Medicaid Services (CMS) in support of the agency’s proposal to reform direct and indirect remuneration (DIR) fees — reform that relates directly to reducing patients’ out-of-pocket drug costs. NACDS issued its comments
February 4, 2019 by Chain Drug Review
Health Mart, Nimesh Jhaveri
February 4, 2019, News
IRVING, Texas — Nimesh Jhaveri has joined the Health Mart family of community pharmacies as president. Jhaveri, who has 30 years of hands-on pharmacy experience, started in his new role on October 31. As president, Jhaveri is responsible for developing strategies supporting the goals and success of more than 5,000 Health Mart pharmacies. In his
February 4, 2019 by Chain Drug Review
brick-and-mortar retailers, digital shopping
February 4, 2019, Opinion
Despite the growing influence of online and digital shopping, over 70% of consumers prefer to shop for consumer packaged goods from retailers with a physical presence — whether shopping in-store or online — as opposed to 29% who shop primarily online, according to results from a recent survey by DXC Technology published in an IDC
February 4, 2019 by Jeffrey Woldt
Stefano Pessina, Walgreens Boots Alliance (WBA)
February 4, 2019, Opinion
Walgreens Boots Alliance has entered the early stages of a profound transition, one that will see the organization pivot from a store-first to a digital-first model. Any lingering doubts about the direction the company is headed were put to rest earlier this month when WBA unveiled a seven-year agreement with Microsoft to harness the power